Stay updated on Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial
Sign up to get notified when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.

Latest updates to the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page shows a new revision tag, updating from v3.6.4 to v3.6.5 to reflect the latest version of the record.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new revision tag v3.6.4 was added to the study record history, and the previous revision tag v3.6.3 was removed. This reflects an update to the page's versioning metadata within the record history.SummaryDifference0.1%

- Check31 days agoNo Change Detected
- Check45 days agoChange DetectedThe study record history now shows the latest revision as v3.6.3, replacing the prior v3.6.2 in the version history.SummaryDifference0.1%

- Check53 days agoChange DetectedA new revision entry (v3.6.2) was added to the study's history, and the previous revision (v3.6.0) was removed from the history, indicating a version update to the page.SummaryDifference0.1%

- Check67 days agoChange DetectedAdded a note that recruitment is no longer being pursued and recorded a new record revision v3.6.0; the previous revision v3.5.5 entry was removed.SummaryDifference0.4%

- Check74 days agoChange DetectedThe study record history shows a new revision label v3.5.5 added, replacing the prior v3.5.4.SummaryDifference0.1%

Stay in the know with updates to Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.